The community standard has moved toward direct-acting oral anticoagulation as this is demonstrated to be more effective than traditional warfarin, safe, and convenient. However, with average costs of 0 per month, costs have prevented widespread adoption of these medications in correctional settings. This presentation analyzes the recent guideline changes that have influenced this community standard and examines benefits and risks of several common anticoagulation protocols.

• Review updated guideline recommendations for anticoagulation in cardiovascular diseases
• Compare the risks and benefits of several common anticoagulation regimens in the correctional setting
• Discuss relative costs, approved indications, and treatment considerations for each member of the direct oral anticoagulation drug class

Level: Intermediate